Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ASML vs GSK✓SelectedUSD · GSKASML vs GSK performance historyLatest closeAs of-0.13%11/13
Stock and ETF performance explorer

ASML vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+47.5%
GSK return
+9.8%
Excess return
+37.7%
Maximum drawdown
-31.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%+0.5%-0.7%-0.1%
7D+4.9%+1.1%+3.8%+5.0%
30D-9.3%+6.3%-15.6%-9.0%
3M-19.0%+1.8%-20.8%-18.6%
6M-5.2%+1.7%-6.9%-5.5%
YTD+40.6%+6.5%+34.1%+44.2%
1Y+47.5%+9.5%+38.0%+50.1%
All+47.5%+9.8%+37.7%+50.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling